A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine in Pediatric Subjects Aged 3 to 6 Years and 6 to 35 Months Old
Clinical trial NCT02777411 · COMPLETED
Trial details
- NCT number
- NCT02777411
- Sponsor
- Enimmune Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-01-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.